Lilac Insights

What Lilac Insights does

Lilac Insights Private Limited, founded in September 2011 and headquartered in Navi Mumbai, India, is a private genetic diagnostic laboratory operating a hub-and-spoke model with a 14,000 sq. ft. central facility and satellite centers in Bangalore, New Delhi, Kolkata, Pune, Indore, and Coimbatore, serving more than 250 cities. The company runs a comprehensive genetic testing portfolio spanning reproductive genetics (prenatal screening, NIPS via exclusive TACS technology from NIPD Genetics, karyotyping, FISH, chromosomal microarray, and NGS-based tests), cancer genetics (solid tumor, hematological malignancy, and sarcoma panels under the Oncoinsights brand), metabolic genetics (newborn screening and Inborn Errors of Metabolism under the carIeM program), and clinical genetics services under the Sujanan Program. Lilac also operates SureT for non-invasive pre-implantation chromosome screening in the IVF segment and launched AtEase, an inclusive mental health platform for women and non-binary individuals.

The company monetizes primarily through one-time diagnostic test fees billed per sample to hospitals, specialists, and patients, with reimbursements of up to Rs. 15,000 for confirmatory testing following high-risk NIPS results. Ancillary revenue streams include pay-as-you-go genetic consultation (Basic, Advanced, and Follow-up tiers delivered in-person or via e-Genetic video counseling), a subscription-based model for AtEase therapy services, and franchise/license fees from entrepreneurs operating Lilac-branded diagnostic centers. Go-to-market is enterprise-led with a field sales team managing 3,000+ corporate hospital and nursing home accounts and 8,000+ referring specialists, supplemented by channel partnerships, CMEs, and digital self-serve booking. The company reports positive EBITDA over recent years, an estimated 251–500 employees, and has cumulatively processed 650,000+ patient samples since inception, with milestone velocity accelerating from 50K (2014) to 550K (2020).

Name

Lilac Insights

Legal name

Lilac Insights Private Limited

Website

https://lilacinsights.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

251–500 employees

Short description

Lilac Insights is a Mumbai-based private genetic diagnostic laboratory offering prenatal screening, NIPS, cancer genetics, and metabolic testing through a pan-India network of 3,000+ hospitals and 8,000+ referring specialists.

Ownership category

akta.pro rank

Product category

Genetic Diagnostic Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Genetic & Prenatal Testing Laboratories (HLAFAMAH)

akta.pro secondary industries

Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI), Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA)

Keywords

• Genetic diagnostic testing
• Prenatal genetic screening
• Cancer genetic testing
• Clinical cytogenetics services
• Metabolic genetics testing

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices8 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Genetic Diagnostic Testing Services: One-time diagnostic testing services for reproductive genetics, cancer genetics, and metabolic genetics including prenatal screening, NIPS, karyotyping, microarray, NGS, and specialized panels. Revenue generated per test conducted for healthcare providers and patients.
2. Genetic Consultation and Counseling: Clinical geneticist and genetic counselor consultations available in-person at select centers (Mumbai, Navi Mumbai, Pune, Bengaluru) and via e-Genetic counseling video conference. Provides three tiers: Basic, Advanced, and Follow-up genetic consultation.
3. Franchisee Partnerships: Franchise model for entrepreneurs to establish Lilac Insights diagnostic centers in their geography. Franchise partners receive training, support, and access to the full test portfolio.
4. AtEase Mental Health Platform: Inclusive mental health platform offering therapy services (Individual, Couples, Family), psychiatric consultations, and corporate emotional wellness for women and non-binary individuals.

Pricing tiers

Go-to-market motion3 records

Distribution channels6 records

Marketing channels7 records

Core offering

Lilac Insights is a NABL-accredited genetic diagnostic laboratory that provides comprehensive genetic testing services across reproductive genetics (prenatal screening, NIPS, karyotyping, microarray), cancer genetics (solid tumor, hematological malignancy, sarcoma panels), metabolic/inborn error of metabolism genetics (newborn screening and management), and clinical genetics consultation/counseling. The company serves healthcare providers through its pan-India network of labs and partnerships and also offers the AtEase mental health platform directly to consumers.

Differentiator

Problem solved

Functional benefit

Brands

• AtEase: Inclusive mental health platform for women and non-binary individuals offering therapy, counseling, and psychiatric consultation services.
• Sujanan Program
• carIeM
• Oncoinsights
• EVICOScreen
• InsighT/InsighT-Adv
• ALTUM

Products and services

• Reproductive Genetics Program Comprehensive reproductive genetic testing program covering prenatal screening, pre- and perinatal diagnostics, recurrent pregnancy loss evaluation, chromosomal abnormality screening, and genetic counseling before conception. Includes NIPS, karyotyping, microarray, NGS-based reproductive panels and FISH, supported by e-Genetic counseling. Target customers are obstetricians, fetal medicine specialists, pregnant women and couples across India.
• Cancer Genetics Program (Oncoinsights) Cancer genetics testing service for solid tumors, hematological malignancies and sarcomas providing prognostication and treatment decision support (chemotherapy, targeted therapy, immunotherapy, palliative care). Targets oncologists, cancer treatment centers and 10,000+ cancer patients served across India.
• Sujanan Program (Clinical Genetics & Genetic Counseling) Clinical genetics and counseling program delivered via Sujanan Clinic (Pune) and e-Genetic counseling for patients across India. Covers genetic consultation in three tiers (Basic, Advanced, Follow-up), newborn screening, fetal autopsy, and metabolic disease management. Targets pediatricians, neonatologists, parents of children with genetic or metabolic disorders and couples seeking pre-conception counseling.
• carIeM Metabolic Testing Program Comprehensive metabolic testing program covering screening, diagnosis, consultation and management of Inborn Errors of Metabolism (IEMs). Includes newborn screening panels (Trio, Tetra, Hepta, Exp, Exp+) and advanced biochemical testing. Delivered by a multidisciplinary team of metabolic geneticists, dietitians and BGCI certified genetic counselors for pediatricians, neonatologists and families of affected newborns.
• AtEase Mental Health Platform Inclusive online mental health platform offering individual therapy, couples therapy, family therapy, psychiatric consultations, and corporate emotional wellness, with focus on women (cis and trans) and non-binary individuals. Delivered as a subscription service accessible via the Lilac Insights website and bookable online.
• InsighT and InsighT-Adv NIPS Tests World's most advanced Non-Invasive Prenatal Screening (NIPS) tests using patented TACS technology, exclusively available in India through Lilac Insights. InsighT screens for 8 common chromosomal conditions (Trisomy 21, 18, 13, SCAs); InsighT-Adv covers 12 conditions including 4 microdeletion syndromes (DiGeorge, Smith-Magenis, Wolf-Hirschhorn, 1p36 deletion). Targets expectant parents and referring OB-GYNs/fetal medicine specialists.
• ALTUM Chromosomal Microarray Comprehensive Chromosomal Microarray (CMA) solution for detecting aneuploidies, microdeletions and microduplications in both prenatal and postnatal applications, with Maternal Cell Contamination (MCC) testing included for all prenatal samples. Targets obstetricians, clinical geneticists and pediatricians requiring high-resolution chromosomal analysis.
• SureT Non-Invasive Chromosome Screening (NICS) Non-Invasive Chromosome Screening test under the Pre-Implantation Genetic Tests (PGT) portfolio for the IVF segment. Lilac Insights became the first Indian company to launch this NICS technology, which helps increase pregnancy rate per embryo transfer and reduce the risk of multiple pregnancies. Targets IVF specialists, fertility clinics and intended parents undergoing IVF.
• EVICOScreen Prenatal Screening Program Exclusively developed prenatal screening reports designed to deliver the complete benefits of evidence- and guideline-based screening tests with comprehensive pregnancy care information in easy-to-understand language for couples. Helps clinicians offer comprehensive pregnancy care and supports informed patient decision-making.
• e-Genetic Counseling & Consultation Service Online video-based genetic consultation and counseling service providing patients nationwide access to Lilac Insights' clinical geneticists and BGCI certified genetic counselors. Available in three tiers (Basic, Advanced, Follow-up) covering chromosomal abnormalities, biochemical screening, ultrasonography findings, pediatric cases, obstetric indications and history of inherited disorders. Targets patients referred by specialists and direct consumer bookings.
• Lilac Insights Franchisee Program Franchise program for entrepreneurs to establish Lilac Insights-branded genetic diagnostic centers in their geography. Franchise partners receive training, operational support, and access to the company's full test portfolio and brand, with existing franchise locations in Indore, Coimbatore, Belgaum, Dhule, Hubli, Jalgaon, Karad, Varanasi and others. Targets SMB entrepreneurs and regional diagnostics business owners.

Quantifiable outcome

• >99% detection rate for Trisomy 21, 18, 13 with InsighT/InsighT-Adv NIPS tests
• +5 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Scale indicators9 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• MedGenome: India's largest genomics-driven diagnostics and research company, offering NIPT, carrier screening, cancer genomics, and NGS panels. Direct competitor in Indian genetic diagnostics with overlapping reproductive and oncology genetics portfolio.
• Strand Life Sciences: India-based genomic profiling and clinical diagnostics company offering hereditary cancer, reproductive genetics, and NGS services. Direct competitor across Lilac's core prenatal and cancer genetics lines.
• MapMyGenome: Indian personal genomics and preventive health company offering genetic tests for carrier screening, cancer risk, and prenatal screening. Competes directly in Indian NIPT and predictive genetics segments.

Broad incumbents

• Thyrocare Technologies: Large pan-India diagnostics network (acquired by PharmEasy) offering preventive and routine diagnostics at low cost. Comparable as an Indian diagnostic infrastructure platform, though Lilac is more specialized in genetics while Thyrocare is broader preventive wellness.
• Metropolis Healthcare: One of India's leading diagnostic chains with 3,000+ collection centers across India and abroad. Comparable footprint and B2B hospital/clinic channel, but broader routine diagnostics rather than genetics specialization.
• Neuberg Diagnostics: Pan-India diagnostic chain with significant presence in genetics, molecular diagnostics, and reproductive testing. Comparable multi-city Indian footprint and genetics offering, though broader portfolio.
• Natera: Global leader in NIPT (Panorama) and reproductive genetics with established technology in cell-free DNA testing. Comparable NIPS product category; poses a competitive threat if it expands Indian distribution.
• Myriad Genetics: Global genetic testing leader with hereditary cancer (BRACAnalysis) and prenatal screening products. Comparable in oncology and reproductive genetics categories, with stronger R&D budget but limited India presence.
• PerkinElmer (now Revvity): Global life sciences and diagnostics company; Lilac's founders previously led genetic screening business at PerkinElmer South Asia. Comparable in reproductive and newborn screening technologies, with broader global scale.

Emerging players

• 4baseCare: India-focused genomics company specializing in oncology molecular profiling and precision oncology. Overlapping cancer genetics focus with Lilac's Oncoinsights program, though more oncology-pure-play.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/lilacinsights
• YouTubeyoutube.com/channel/lilacinsights
• Facebookfacebook.com/lilacinsights
• LinkedInlinkedin.com/company/lilac-insights
• Instagraminstagram.com/lilacinsights

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lilac Insights